Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.

Lee S Rosen; Ehtesham Abdi; Ian D Davis; John Gutheil; Frederick M Schnell; John Zalcberg; Alessandra Cesano; Urte Gayko; Mon-Gy Chen; Stephen Clarke

doi:10.1200/JCO.2005.04.1152

Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.

Identifier:nobleid.org/w1/20260515/5B286BC6

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5B286BC6.svg?ark=w1%2F20260515%2F5B286BC6)](https://nobleid.org/work/w1/20260515/5B286BC6)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.

Identifier:nobleid.org/w1/20260515/5B286BC6

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5B286BC6.svg?ark=w1%2F20260515%2F5B286BC6)](https://nobleid.org/work/w1/20260515/5B286BC6)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work